Working… Menu

High Myopia: Extended and Longterm Observation of Pathologic Myopia Patients With the Risk for Developing a Myopic Choroidal Neovascularization (CNV) (HELP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03070717
Recruitment Status : Completed
First Posted : March 3, 2017
Last Update Posted : July 19, 2019
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 23, 2019
Actual Study Completion Date : May 23, 2019